Company founded by 糖心原创鈥檚 Caroline Cao awarded $150,000 Ohio Third Frontier grant
May 14, 2019
May 14, 2019
A startup company founded by 糖心原创 professor Caroline Cao has been awarded $150,000 in state funding to develop and commercialize a radiation-free alternative to X-ray imaging during minimally invasive surgery.
Cao, professor of in the , is founder of Endo Guidance Technologies, a Dayton startup company.
Endovascular surgery is a minimally invasive approach to treat cardiovascular diseases such as plaque buildup in vessels or aneurysms. Surgeons must insert guidewires and catheters into the patient鈥檚 blood vessels. This is done blind, guided only by fluoroscopy (X-ray imaging) when needed.
Recovery time for the patients is much faster, with lower rates of infection and decreased pain and suffering.
Cao headed a team of researchers who that could eliminate the need for radiation-emitting X-rays in the image-guided minimally invasive surgical procedures.
She is working on the prototype of a lightweight sensor and display that would help guide surgeons in endovascular surgery 鈥 similar to a GPS for endovascular surgery 鈥 without exposing themselves or their patients to radiation.
The award to Endo Guidance Technologies is part of $2.25 million approved by the Ohio Third Frontier Commission to give birth to new technologies and move them out of the lab and into the marketplace.
鈥淥hio鈥檚 world-class research and medical institutions are developing breakthrough technologies,鈥 said Lydia L. Mihalik, director of the Ohio Development Services Agency and chair of the Ohio Third Frontier Commission. 鈥淲e are helping get these products to market where they can make a difference.鈥
The Ohio Third Frontier Technology Validation and Start-up Fund provides grants to Ohio institutions of higher education and other nonprofit research institutions and Ohio startup companies. The funding is to demonstrate that a technology is commercially viable through activities such as testing and prototyping. The ultimate goal is to commercialize the technologies.
It is the first technology Cao has worked to commercialize.
鈥淭hings we invent in the lab don鈥檛 usually get to this point,鈥 she said. 鈥淏ut this is both innovative and useful. It will change the way surgeons do work and will be a great benefit to the patients. And we鈥檒l all become patients someday.鈥
Cao is also a professor of in the College of Engineering and Computer Science and professor of surgery in the . She was the Ohio Research Scholar for the Ohio Imaging Research and Innovation Network from 2012 to 2015 and is an expert in the design and evaluation of enabling technology, such as haptics, navigational aids and surgical simulation for minimally invasive surgery.